PEOPLE - Tactile Systems Technology makes appointment:
This article was originally published in Clinica
Lymphoedema treatment specialist Tactile Systems Technology has appointed Gerald Mattys as CEO. Mr Mattys has held numerous general management positions in the past 10 years, including two CEO assignments. His sales and marketing management career includes stints at Respironics and Edentech. Mr Mattys is to spearhead the company's growth as it commercialises its proprietary medical device for non invasive treatment of lymphoedema.
You may also be interested in...
Through a draft guidance, the US agency has established performance criteria for magnetic resonance coils, making the devices eligible for the standards-based Safety and Performance Based Pathway.
Singapore recalls trigger international reaction as metformin is added to growing list of chronic medications found to contain NDMA.
Draft recommendation offers path to ICH Q12 regulatory relief.